Advanced Therapies Congress, 24-25 May, 2022, ExCel, London

On the 24th of May, 2022, PMM team members, Xuanqi Song and Sam Jarada, attended the Advanced Therapies Congress held at the London ExCeL. The Advanced Therapies Congress explored, defined, and attempted to tackle the main challenges currently being faced when it comes to the development of patient access to advanced therapy medicinal products (ATMP). […]

COVID-19: How will testing and vaccines have to adapt to new variants?

Joana Vidigueira   Abbreviations SARS: Severe Acute Respiratory Syndrome, CoV: coronavirus, MERS: Middle Eastern Respiratory Syndrome, DNA: deoxyribonucleic acid, RNA: ribonucleic acid, ACE2: angiotensin-converting enzyme 2, APC: antigen presenting cells, mRNA: messenger RNA, RT-PCR: reverse transcription polymerase chain reaction Introduction Viruses are biological agents that are only able to survive and multiply within a living […]

Pharmacogenomics: The future of medicine?

Celeste Cohen           Picture credit: National Human Genome Research Institute         Note: All terms shown in bold are defined in the glossary at the end of the article. Defining Pharmacogenomics From chemotherapy to HIV drugs, the past century has seen rapid advances in medical innovation, which have given rise to a wide range […]

What is meant by the terms Personalized and Precision Medicine?

Lovisa Lindquist Currently, the majority of healthcare systems around the world employ a ‘one-size-fits-all’ approach when treating patients that have been diagnosed with the same disease, meaning that people with the same diagnosis will most likely be prescribed the same treatment [1]. However, through the use of sophisticated molecular techniques that have been developed in […]

Huntington’s disease: prevention and current innovations in treatment

Huntington’s disease: prevention and current innovations in treatment Jenny ChatzigerouHuntington’s disease (HD) is a genetic neurodegenerative disorder that was first described in 1872 by the physician George Huntington,1 in his seminal paper ‘On Chorea’.  Huntington described the condition as a hereditary, progressive, adult-onset disease that caused patients to suffer from a range of cognitive, motor, […]